HQL
Tekla Life Sciences Investors
17.70$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.0% | – | – | – | – | – | – | 0.0% | – | – | – | -2.7% | |
| -16,168.9% | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0% | – | – | – | – | – | – | – | – | – | – | -0.2% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | – | 0.0% | 0.0% | 0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | 29.2% | |
| 1.6% | – | – | – | – | – | – | – | – | – | – | 36.6% | |
| 6.0% | – | – | – | – | – | – | – | – | – | – | -36.6% | |
| 0.0% | – | – | – | – | – | – | 0.0% | – | 0.0% | – | 0.1% | |
| -6.0% | – | – | – | – | – | – | 0.0% | – | – | – | -2.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.